ImmunityBio (IBRX)
NASDAQ:IBRX

ImmunityBio (IBRX) Stock Forecast & Price Target

546 Followers
See the Price Targets and Ratings of:
See bloggers sentiment and opinion on IBRX
>

IBRX Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
ImmunityBio
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

IBRX Stock 12 Months Forecast

There Are No Analyst Ratings for IBRX In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

IBRX Financial Forecast

IBRX Earnings Forecast

Next quarter’s earnings estimate for IBRX is -$0.23 with a range of -$0.26 to -$0.21. The previous quarter’s EPS was -$0.27. IBRX beat its EPS estimate 33.33% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.64% of the time in the same period. In the last calendar year IBRX has Underperformed its overall industry.
Next quarter’s earnings estimate for IBRX is -$0.23 with a range of -$0.26 to -$0.21. The previous quarter’s EPS was -$0.27. IBRX beat its EPS estimate 33.33% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.64% of the time in the same period. In the last calendar year IBRX has Underperformed its overall industry.

IBRX Sales Forecast

Next quarter’s sales forecast for IBRX is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $360.00K. IBRX beat its sales estimates 66.67% of the time in past 12 months, while its overall industry beat sales estimates 44.68% of the time in the same period. In the last calendar year IBRX has Outperformed its overall industry.
Next quarter’s sales forecast for IBRX is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $360.00K. IBRX beat its sales estimates 66.67% of the time in past 12 months, while its overall industry beat sales estimates 44.68% of the time in the same period. In the last calendar year IBRX has Outperformed its overall industry.

IBRX Analyst Recommendation Trends

IBRX has not received any ratings in the last 3 months.
IBRX has not received any ratings in the last 3 months.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler
$4.00
Hold
136.69%
Upside
Downgraded
ImmunityBio downgraded to Neutral from Overweight at Piper SandlerImmunityBio downgraded to Neutral from Overweight at Piper Sandler
Jefferies
$5.00
Buy
195.86%
Upside
Reiterated
ImmunityBio (IBRX) Gets a Buy from Jefferies - TipRanks.comJefferies analyst Kelly Shi maintained a Buy rating on ImmunityBio ( IBRX Research Report) on May 12 and set a price target of $5.00. The companys shares closed last Friday at $2.28.

Best Analysts Covering ImmunityBio

Which Analyst Should I Follow If I Want to Buy IBRX and Sell After:
1 Month
Kelly ShiJefferies
Success Rate
2/3 ratings generated profit
67%
Average Return
-3.43%
reiterated a buy rating 5 months ago
Copying Kelly Shi's trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of -3.43% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Kelly ShiJefferies
Success Rate
1/3 ratings generated profit
33%
Average Return
-12.50%
reiterated a buy rating 5 months ago
Copying Kelly Shi's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -12.50% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Kelly ShiJefferies
Success Rate
0/3 ratings generated profit
0%
Average Return
-45.90%
reiterated a buy rating 5 months ago
Copying Kelly Shi's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -45.90% per trade.
2 Years
Kelly ShiJefferies
Success Rate
0/3 ratings generated profit
0%
Average Return
-49.63%
reiterated a buy rating 5 months ago
Copying Kelly Shi's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -49.63% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

IBRX Stock Forecast FAQ

What is IBRX’s average 12-month price target, according to analysts?
Currently, no data Available
What is IBRX’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IBRX, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is IBRX a Buy, Sell or Hold?
      Currently, no data Available
      What is ImmunityBio’s price target?
      Currently, no data Available
      What do analysts say about ImmunityBio?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of IBRX?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis